Director - Pharmacokinetics and Scientific Affairs (CPU)

Medpace, Inc. is actively seeking a Director, Pharmacokinetics and Scientific Affairs for their new confined (Phase I, IIa) Clinical Pharmacology Unit (CPU). This individual will provide scientific leadership in designing studies and planning methods of analysis for clients’ clinical studies. The responsibilities will include the interpretation of the results of all clinical pharmacology studies, Phase I and non-routine pharmacokinetic studies and approval of the protocols and reports; critical evaluation and approval of the study designs; results interpretation and reports for all routine pharmacokinetics protocols; discussion with clients and with regulatory bodies (FDA) of the results of these studies and their interpretation; and suggesting new marketing strategies based on the application of scientific know-to client scientific or regulatory compliance issues.

Medpace offers an outstanding compensation and benefits package, including health, dental, PTO, 401(k) with match, profit sharing and bonuses based on individual and company performance. To apply for this position, please fax a resume and cover letter to: 513-579-0444 or E-mail to: [Click here for email]. EOE.
REQUIREMENTS
Candidate must have a Ph.D. in clinical pharmacology, pharmacokinetics or an equivalent field with experience in phase I, bioequivalence, biostatistics, and pharmacokinetics studies. They will need to be skilled at scientific writing and communications, client relations, research design, statistical analysis and analysis, and possess knowledge of FDA requirements for clinical studies.